Predicta Biosciences is a precision oncology company that integrates cutting-edge multiomics and liquid biopsies to create innovative diagnostic and therapeutic products. By eliminating the need for invasive bone-marrow biopsies with blood-based tests, Predicta enables earlier detection, frequent longitudinal monitoring, and potential individualization of therapy selection.
| Website | http://predictabiosciences.com |
| Employees | 22 (14 on RocketReach) |
| Founded | 2023 |
| Address | 750 Main St, Cambridge, Massachusetts 02139, US |
| Industry | Biotechnology Research |
| Keywords | Precision Oncology, Cancer Diagnostics, Oncology Diagnostics, Multiomics, Diagnostic Products, Molecular Diagnostics, Clinical Diagnostics, Therapeutic Products, Cancer Research, Early Cancer Detection, Oncology Therapeutics, Genomic Testing, Biomarker Discovery, Personalized Medicine, Cancer Treatment, Drug Development, Biotechnology |
| Competitors | Guardant Health, Exact Sciences, Freenome, GRAIL, Caris Life Sciences, Foundation Medicine, OncoDNA, Tempus Labs, Inc., NeoGenomics Laboratories, Myriad Genetics +41 more (view full list) |
Looking for a particular Predicta Biosciences employee's phone or email?
François Aguet is the SVP Research and Computational Biology of Predicta Biosciences.
14 people are employed at Predicta Biosciences.
Predicta Biosciences is based in Cambridge, Massachusetts.